Td Waterhouse Canada Inc. Acurx Pharmaceuticals, Inc. Call Options Transaction History
Td Waterhouse Canada Inc.
- $14.8 Trillion
- Q2 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding ACXP
# of Institutions
30Shares Held
1.21MCall Options Held
14.3KPut Options Held
18.3K-
Vanguard Group Inc Valley Forge, PA492KShares$968,6230.0% of portfolio
-
Prospect Financial Services LLC Melville, NY278KShares$547,8570.48% of portfolio
-
Geode Capital Management, LLC Boston, MA130KShares$256,1290.0% of portfolio
-
Lpl Financial LLC Fort Mill, SC53.7KShares$105,8570.0% of portfolio
-
Morgan Stanley New York, NY46.4KShares$91,4090.0% of portfolio
About Acurx Pharmaceuticals, Inc.
- Ticker ACXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,556,600
- Market Cap $22.8M
- Description
- Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The com...